Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis
Open Access
- 10 November 2009
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 101 (10), 1664-1670
- https://doi.org/10.1038/sj.bjc.6605361
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatmentEuropean Journal of Surgical Oncology, 2008
- Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell linesZeitschrift für Krebsforschung und Klinische Onkologie, 2008
- Systemic Treatment of Colorectal CancerGastroenterology, 2008
- Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissuesThe Prostate, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Randomized Trial of Laparoscopic-Assisted Resection of Colorectal Carcinoma: 3-Year Results of the UK MRC CLASICC Trial GroupJournal of Clinical Oncology, 2007
- Human Tribbles-1 Controls Proliferation and Chemotaxis of Smooth Muscle Cells via MAPK Signaling PathwaysPublished by Elsevier BV ,2007
- TRB3 modulates C2C12 differentiation by interfering with Akt activationBiochemical and Biophysical Research Communications, 2007
- Skeletal Muscle-Selective Knockout of LKB1 Increases Insulin Sensitivity, Improves Glucose Homeostasis, and Decreases TRB3Molecular and Cellular Biology, 2006
- PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3Nature Medicine, 2004